William Vermi

19.1k citations
157 papers · 12.3k indexed · 5 hit papers · h-index 54

William Vermi

156 papers receiving 12.2k citations

Hit Papers

Intraepithelial Type 1 Innate Lymphoid Cells...73420012026200920172505007501000

Peers

William Vermi
Comparison fields: 5 of 127
  • Immunology 8.5k
  • Oncology 3.4k
  • Dermatology 670
  • Neurology 614
  • Immunology and Allergy 450
Replace Creg J. Workman with:
Creg J. Workman United States
Alejandro V. Villarino United States
Lorenzo Cosmi Italy
Boris Reizis United States
Rosanne Spolski United States
Marc A. Gavin United States
Theresa L. Murphy United States
Jonathon D. Sedgwick Australia
Antal Rot Austria
Lori Fitz United States
William Vermi relative to Creg J. Workman United States Creg J. Workman's profile →
Citations per field
00.5×1.5×2.3×
Creg J. Workman · 1×
Citations per year

Countries citing papers authored by William Vermi

Since Specialization
Citations

This map shows the geographic impact of William Vermi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Vermi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Vermi more than expected).

Fields of papers citing papers by William Vermi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Vermi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Vermi. The network helps show where William Vermi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside William Vermi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William Vermi Line = papers co-authored together William Vermi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20237
2 20233
3 20238
4 202220
5 202231
6 202123
7 202110
8 2021129
9 202028
10 202021
11 201930
12 201859
13 201829
14 201326
15 201362
16 2012257
17 201157
18 2005116
19 2004139
20 199939

About William Vermi

William Vermi is a scholar working on Immunology, Immunology and Allergy and Oncology, having authored 157 papers that have together received 12.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (55 papers), Immunotherapy and Immune Responses (47 papers), T-cell and B-cell Immunology (44 papers), Immune cells in cancer (23 papers), Immune Response and Inflammation (17 papers), Cell Adhesion Molecules Research (14 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Immunology (8.5k citations), Oncology (3.4k citations) and Dermatology (670 citations). William Vermi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Marco Colonna, Fabio Facchetti, Marina Cella, Susan Gilfillan, Silvia Lonardi, Anja Fuchs, Robert D. Schreiber, Yaming Wang, Karel Otero and Mark J. Smyth. Their work appears in journals such as Blood, Cancers, The Journal of Experimental Medicine, Frontiers in Immunology and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026